Target intelligence / Profile preview

Influenza Hemagglutinin Antigen H1N1 Subtype A Virus Protein (HA)

Target
HA
Molecular classification
Viral protein, Surface glycoprotein
01

Overview

Influenza hemagglutinin (HA) is a surface glycoprotein and the principal antigen of the influenza A virus, including the H1N1 subtype. It plays a central role in viral infectivity and immune recognition. HA is responsible for binding to host cell receptors and mediating fusion between the viral envelope and host cell membrane, enabling viral entry. It is a homotrimeric protein, with each monomer comprising a globular head domain (receptor binding) and a stem domain (membrane fusion). The mature HA protein results from cleavage of an inactive precursor (HA0) into two subunits: HA1 (head) and HA2 (stem), which remain linked by a disulfide bond. HA is a major target of neutralizing antibodies, and its rapid evolution through mutation leads to frequent emergence of new strains capable of evading pre-existing immunity. This necessitates regular updates to seasonal vaccines. Its critical role as both an attachment factor/receptor binder *and* fusion protein makes it a prime target for antiviral drugs, monoclonal antibodies, diagnostics, surveillance programs, and vaccine design efforts.

Other names
HemagglutininH1N1 HemagglutininHA proteinInfluenza HAH1HA1 (subunit)HA2 (subunit)
02

Mechanism of action

Binding to sialic acid receptors on host cells, mediating fusion of viral and host cell membranes.

03

Biological functions

Receptor bindingMembrane fusionViral entryAntigen presentationHemagglutination
04

Disease associations

InfectionInfluenzaPandemicViral disease
05

Safety considerations

Antigenic drift (mutation leading to immune evasion)Strain-specific immunityPotential for pandemic emergenceLimited efficacy of some vaccines due to antigenic variation
06

Interacting drugs

Monoclonal antibodies (e.g., broadly neutralizing antibodies)

1 more in the full profile.

07

Biomarkers

Antibody titers (hemagglutination inhibition assay)Viral loadHA sequence variants

Beyond the preview

Go deeper on Influenza Hemagglutinin Antigen H1N1 Subtype A Virus Protein (HA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Influenza Hemagglutinin Antigen H1N1 Subtype A Virus Protein (HA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call